- Dodgy Data Firm Behind Retracted Hydroxychloroquine Study Raises Questions Over Haphazard Decisions
by Tyler Durden, https://www.zerohedge.com/
A data analytics firm behind an influential – and now retracted Lancet study which concluded that Hydroxychloroquine is dangerous, has one employee and is headquartered in a residential house just west of Chicago. Yet its bogus data prompted the World Health Organization, the UK and France to halt clinical trial programs involving the controversial drug used to treat COVID-19.
The data firm, Surgisphere, was founded by 41-year-old Sapan Desai, an MBA who also holds a medical degree and a Ph.D. who is named on both The Lancet study and another now-retracted article in the New England Journal of Medicine. He has refused to explain how his tiny data analytics firm was able to procure their dodgy data after questions were raised over troubling inconsistencies – despite a letter to The Lancet from over 200 scientists demanding greater transparency regarding the hospitals where medical data came from, according to Bloomberg.
“There is an almighty rush to understand this new disease — everybody is trying to get data quickly,” said said Nicholas Day, a professor of tropical medicine at the University of Oxford’s branch in Bangkok. “All the journals are desperate to publish because there is a thirst to know about this disease. Therefore mistakes are made, stuff is rushed through.“